Volume 4, Issue 2, Pages (February 1996)

Slides:



Advertisements
Similar presentations
Volume 15, Issue 2, Pages (August 2001)
Advertisements

Functional comparison of thymic B cells and dendritic cells in vivo
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
Volume 86, Issue 1, Pages (July 1996)
Volume 8, Issue 1, Pages (January 1998)
Volume 7, Issue 2, Pages (February 2001)
Volume 13, Issue 5, Pages (November 2000)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Volume 4, Issue 4, Pages (April 1996)
Volume 5, Issue 3, Pages (September 1996)
Volume 7, Issue 4, Pages (October 1997)
Volume 7, Issue 6, Pages (December 1997)
Volume 87, Issue 6, Pages (December 1996)
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 5, Pages (November 1999)
How Much TCR Does a T Cell Need?
Volume 5, Issue 5, Pages (November 1996)
Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development  Na Xiong, Chulho Kang, David H Raulet 
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Volume 11, Issue 4, Pages (October 1999)
Volume 7, Issue 4, Pages (October 1997)
Volume 87, Issue 6, Pages (December 1996)
Volume 9, Issue 4, Pages (October 1998)
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Volume 10, Issue 5, Pages (November 2002)
Volume 10, Issue 5, Pages (May 1999)
Balthazar B Cazac, Jürgen Roes  Immunity 
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Jürgen Ruland, Gordon S Duncan, Andrew Wakeham, Tak W Mak  Immunity 
Targeted Complementation of MHC Class II Deficiency by Intrathymic Delivery of Recombinant Adenoviruses  Ronald Rooke, Caroline Waltzinger, Christophe.
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 20, Issue 1, Pages (January 2004)
CD22 is a negative regulator of B-cell receptor signalling
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Volume 5, Issue 3, Pages (September 1996)
Volume 7, Issue 1, Pages (July 1997)
Volume 14, Issue 5, Pages (May 2001)
Both E12 and E47 Allow Commitment to the B Cell Lineage
Positive Selection of Dendritic Epidermal γδ T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors  Na Xiong, Chuhlo Kang,
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
Volume 15, Issue 5, Pages (November 2001)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 85, Issue 6, Pages (June 1996)
Fateh Ouaaz, Joseph Arron, Ye Zheng, Yongwon Choi, Amer A Beg  Immunity 
Volume 84, Issue 4, Pages (February 1996)
APOE Gene Targeting (A) Schematic representation of the endogenous APOE locus, the gene targeting vector and the targeted APOE locus. The exons of the.
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 16, Issue 3, Pages (March 2002)
Volume 8, Issue 1, Pages (January 1998)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
CD83 Expression Influences CD4+ T Cell Development in the Thymus
Volume 9, Issue 3, Pages (September 1998)
Volume 94, Issue 2, Pages (July 1998)
David A Schwarz, Carol D Katayama, Stephen M Hedrick  Immunity 
B Cell Development under the Condition of Allelic Inclusion
Volume 86, Issue 1, Pages (July 1996)
Cell-Autonomous Defects in Dendritic Cell Populations of Ikaros Mutant Mice Point to a Developmental Relationship with the Lymphoid Lineage  Li Wu, Aliki.
Volume 23, Issue 4, Pages (October 2005)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Volume 84, Issue 2, Pages (January 1996)
Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor γδ+ gut intraepithelial.
Volume 4, Issue 5, Pages (May 1996)
Volume 84, Issue 4, Pages (February 1996)
Control of B Cell Production by the Adaptor Protein Lnk
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Volume 4, Issue 2, Pages 167-178 (February 1996) Mice Lacking the MHC Class II Transactivator (CIITA) Show Tissue-Specific Impairment of MHC Class II Expression  Cheong-Hee Chang, Sylvie Guerder, Soon-Cheol Hong, Willem van Ewijk, Richard A Flavell  Immunity  Volume 4, Issue 2, Pages 167-178 (February 1996) DOI: 10.1016/S1074-7613(00)80681-0

Figure 1 Construction of Targeting Vector and Southern Blot Analysis (A) The line represents the genomic sequences of CIITA locus. Closed and shaded boxes represent neo and tk cassette, respectively. Arrows indicate primers used for PCR to screen homologous recombinants. The probe used for Southern blot analysis is shown at the bottom. Abbreviations for restriction sites are as follows: B, BamHI; Xb, XbaI; Xh, XhoI; RI, EcoRI. (B) Analysis of offspring from CIITA heterozygote intercrosses. Tail DNA was digested with BamHI and EcoRI and analyzed by Southern blotting with the probe indicated in (A). Wild-type and the recombined alleles are shown. (C) Northern blot analysis of poly(A)+ mRNA from CIITA (+/+) and CIITA (−/−) mice. The membrane was hybridized with a probe derived from the human CIITA cDNA (DraIII–NotI). Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 1 Construction of Targeting Vector and Southern Blot Analysis (A) The line represents the genomic sequences of CIITA locus. Closed and shaded boxes represent neo and tk cassette, respectively. Arrows indicate primers used for PCR to screen homologous recombinants. The probe used for Southern blot analysis is shown at the bottom. Abbreviations for restriction sites are as follows: B, BamHI; Xb, XbaI; Xh, XhoI; RI, EcoRI. (B) Analysis of offspring from CIITA heterozygote intercrosses. Tail DNA was digested with BamHI and EcoRI and analyzed by Southern blotting with the probe indicated in (A). Wild-type and the recombined alleles are shown. (C) Northern blot analysis of poly(A)+ mRNA from CIITA (+/+) and CIITA (−/−) mice. The membrane was hybridized with a probe derived from the human CIITA cDNA (DraIII–NotI). Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 1 Construction of Targeting Vector and Southern Blot Analysis (A) The line represents the genomic sequences of CIITA locus. Closed and shaded boxes represent neo and tk cassette, respectively. Arrows indicate primers used for PCR to screen homologous recombinants. The probe used for Southern blot analysis is shown at the bottom. Abbreviations for restriction sites are as follows: B, BamHI; Xb, XbaI; Xh, XhoI; RI, EcoRI. (B) Analysis of offspring from CIITA heterozygote intercrosses. Tail DNA was digested with BamHI and EcoRI and analyzed by Southern blotting with the probe indicated in (A). Wild-type and the recombined alleles are shown. (C) Northern blot analysis of poly(A)+ mRNA from CIITA (+/+) and CIITA (−/−) mice. The membrane was hybridized with a probe derived from the human CIITA cDNA (DraIII–NotI). Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 2 Expression of MHC Class II Molecules (A) Cell surface expression of conventional MHC class II molecules. Single-cell suspensions were prepared from spleen of wild-type (+/+) and CIITA-deficient mice (−/−). Cells (1 × 106) were analyzed by two-color staining using biotinylated I-Ab (AF6-120, Pharmingen) followed by phycoerythrin-conjugated avidin and fluorescein isothiocyanate (FITC)-conjugated B220 (RA3–6B2, Pharmingen) for B cells, FITC-conjugated N418 (gift of K. Bottomly, Yale University) for dendritic cells, or FITC-conjugated MacI for macrophages (gift of K. Bottomly, Yale University). (B) The expression of nonconventional MHC class II molecules. Total RNA was prepared from spleen and first-strand cDNA was synthesized using 2 μg of DNAse I-digested RNA and reverse transcriptase (GIBCO BRL). PCR was performed as described previously (Chang et al. 1994). Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 2 Expression of MHC Class II Molecules (A) Cell surface expression of conventional MHC class II molecules. Single-cell suspensions were prepared from spleen of wild-type (+/+) and CIITA-deficient mice (−/−). Cells (1 × 106) were analyzed by two-color staining using biotinylated I-Ab (AF6-120, Pharmingen) followed by phycoerythrin-conjugated avidin and fluorescein isothiocyanate (FITC)-conjugated B220 (RA3–6B2, Pharmingen) for B cells, FITC-conjugated N418 (gift of K. Bottomly, Yale University) for dendritic cells, or FITC-conjugated MacI for macrophages (gift of K. Bottomly, Yale University). (B) The expression of nonconventional MHC class II molecules. Total RNA was prepared from spleen and first-strand cDNA was synthesized using 2 μg of DNAse I-digested RNA and reverse transcriptase (GIBCO BRL). PCR was performed as described previously (Chang et al. 1994). Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 4 Expression of Ii and H-2M Genes in CIITA (+/+) and (−/−) Mice Total RNA was prepared from spleen and first-strand cDNA was synthesized using 2 μg of DNAse I-digested RNA and reverse transcriptase (GIBCO BRL). PCR was performed as described (Chang et al. 1994). The control lane has the same components except first-strand product. Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 3 Immunohistochemistry of Thymic Sections of CIITA (−/−) Mice Thymic section of the wild-type (A) and CIITA (−/−) (B) mice were stained with M5/114 for MHC class II molecules. Adjacent sections of CIITA (−/−) mice were stained with NLDC145 (C), ER-TR5 (D), a mix of three anti-macrophage monoclonal antibodies (F4/80, ER-MP3, ER-TR9) (E), and ER-TR7 (F). C, cortex; M, medulla; ca, thymic capsule. The arrows in B–F indicate the cortico–medullary junction. The asterisk indicates reticular-free domains. Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 5 Analysis of T Cells from CIITA-Deficient Mice Single-cell suspension was prepared from lymph nodes (A) and thymus (B) of control (+/+) and CIITA (−/−) mice and analyzed by three-color flow cytometry as described in Experimental Procedures. The leftmost panels are dot-plots of cells stained for CD4 and CD8. To the right are profiles of each staining indicated for gated CD4+CD8− and CD4−CD8+ populations. Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 6 Proliferative Response of T Cells (A–B) Response of lymph node T cells to ConA (A) or anti-CD3 antibody stimulation (B). T cells (2 × 105) from CIITA (+/+) (open circles) and CIITA (−/−) (open squares) mice were stimulated with different concentrations of stimuli for 72 hr. Proliferative responses were measured by [3H]thymidine incorporation. (C–D) Allogeneic response of T cells against B10.BR splenocytes (C) or bm12 splenocytes (D). Lymph node cells (2 × 105) from CIITA (+/+) (circles) and CIITA (−/−) (squares) mice were stimulated with different numbers of allogeneic splenocytes (open symbols) or syngeneic C57BL/6 (B6) splenocytes (closed symbols) for 72 hr. (E) KLH recall response of T cells. Lymph node T cells were isolated from CIITA (+/+) (open circles) and CIITA (−/−) (open squares) mice immunized in vivo with 50 μg of KLH and stimulated in vitro in the presence of increasing amount of KLH. For comparison, unimmunized CIITA (+/+) (closed circles) and CIITA (−/−) (closed squares) are shown. Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)

Figure 7 T Cell Profiles from Chimeric Mice after Fetal Liver Cell Transfer Lymph node T cells were prepared and stained with CD4 and CD8 antibodies as described. (A) Lymph node cells from an irradiated CIITA (+/+) animal reconstituted with CIITA (+/+) fetal liver cells. (B) Lymph node cells from an irradiated CIITA (−/−) animal reconstituted with CIITA (+/+) fetal liver cells. (C) Lymph node cells from an irradiated CIITA (+/+) animal reconstituted with CIITA (−/−) fetal liver cells. (D) Lymph node cells from an irradiated CIITA (−/−) animal reconstituted with CIITA (−/−) fetal liver cells. (E) Spleen cells from an irradiated CIITA (−/−) animal reconstituted with CIITA (+/+) fetal liver cells. (F) Spleen cells from an irradiated CIITA (+/+) animal reconstituted with CIITA (−/−) fetal liver cells. (G and H) Lymph node cells from an irradiated C57BL/6 Thy1.1 animal reconstituted with CIITA (−/−) fetal liver cells. We scored 25,000 events. Immunity 1996 4, 167-178DOI: (10.1016/S1074-7613(00)80681-0)